StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
TTFL.BO$41.03-1.61%
Fair $41.03+0.0%

TTFL.BO

Trident Texofab Limited

Consumer Cyclical / Textile ManufacturingBSE

$41.03

-0.67 (-1.61%)

Fairly Valued+0.0%Fair Value $41.03Fund rank 24/100 · Data gapFallback financials|
SA 40/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $26.6M · quality 40.0/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · TTFL.BOLocal privado en este navegador · Trident Texofab Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$615M

P/E

21.3x

↑

EV/EBITDA

7.4x

↓

ROE

5.3%

↑

Gross Margin

11.8%

↓

Debt/Equity

0.63

↑
52-Week Range$41
$39$379

TradingView lightweight chart

TTFL.BO price, volumen y niveles de valoración

Último $41.03Periodo +134.2%
Fair value: $41.03

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+13.1%

FCF CAGR

—

FCF margin

-11.2%

FCF / Net income

-5.47x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.22B · net income $25.1M · FCF $-137.2M

2022-FY → 2025-FY

Gross margin

11.8%-2.0% pts

Operating margin

4.7%-0.7% pts

Net margin

2.1%+0.9% pts

FCF margin

-11.2%-8.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.22B$1.22B$994.8M$963.6M$842.9M
Net Income$25.1M$25.1M$10.8M$22.2M$9.8M
EBITDA$105.1M$105.1M$85.5M$99.3M$67.4M
EPS2.152.151.072.200.98
Gross Margin11.8%11.8%14.5%15.3%13.8%
Operating Margin4.7%4.7%6.3%6.8%5.4%
Net Margin2.1%2.1%1.1%2.3%1.2%
Balance Sheet
Debt/Equity0.630.632.472.513.14
Cash Flow
Free Cash Flow$-137.2M$-137.2M$26.6M$56.4M$-27.6M
Returns
ROE5.3%5.3%6.6%14.6%7.6%
Valuation
P/E21.2621.2647.4127.8485.92
EV/EBITDA7.377.3710.6710.0318.61
P/B1.021.023.154.066.54
Growth & Yield
Revenue Growth22.7%22.7%3.2%14.3%—
EPS Growth100.1%100.1%-51.3%124.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

19.3%

exigente

EPS terminal req.

$3.64

Spread vs growth

80.8%

5Y implied EPS CAGR

15.5%

exigente

EPS terminal req.

$4.41

Spread vs growth

84.6%

10Y implied EPS CAGR

12.7%

razonable

EPS terminal req.

$7.09

Spread vs growth

87.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -79.5%

Total return

-79.5%

Start / end P/E

186.9x → 19.1x

EPS bridge

1.07 → 2.15

Residual

-89.9%

EPS growth+100.1%
Multiple rerating-89.8%
Dividend+0.0%
Residual / FX / buybacks / cross-term-89.9%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.